Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CAD Middle East Pharmaceutical Industries is a Saudi Arabian pharmaceutical company specializing in the production of high-quality Active Pharmaceutical Ingredients (APIs). Established as the first API manufacturing facility in the Gulf Cooperation Council (GCC) region, the company operates a state-of-the-art plant in Sudair Industrial and Business City. CAD Middle East focuses on a wide range of therapeutic areas, including cardiovascular, central nervous system, and anti-diabetic treatments. The company provides both generic APIs and contract manufacturing services to regional and international pharmaceutical formulators. Its facilities are designed to meet international Good Manufacturing Practice (GMP) standards, supporting the Saudi Vision 2030 goal of localizing drug production. By bridging the gap in the local supply chain, CAD Middle East plays a critical role in enhancing drug security within the Middle East and North Africa region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAD Middle East Pharmaceutical Industries.